LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Associations between COVID-19 and 30-day thromboembolic events and mortality in people with dementia receiving antipsychotic medications.

Harrison, Stephanie L / Buckley, Benjamin J R / Lane, Deirdre A / Underhill, Paula / Lip, Gregory Y H

Pharmacological research

2021  Volume 167, Page(s) 105534

Abstract: ... to determine: 1) if COVID-19 is associated with 30-day thromboembolic events and mortality for people ... of antidepressants and anticonvulsants. The odds of 30-day thromboembolic events and all-cause mortality were ... for people aged ≥ 65 years with dementia, COVID-19 and use of antipsychotics in the 30-days prior to COVID-19 ...

Abstract Background: Antipsychotic medications are frequently prescribed to people with dementia to manage behavioural and psychological symptoms. Using a global federated research network, the objectives were to determine: 1) if COVID-19 is associated with 30-day thromboembolic events and mortality for people with dementia receiving antipsychotic medications; and 2) if the proportion of people with dementia receiving antipsychotics is higher during the COVID-19 pandemic compared to 2019.
Methods: A retrospective cohort study was conducted using TriNetX, a global federated health research network. The network was searched for people aged ≥ 65 years with dementia, COVID-19 and use of antipsychotics in the 30-days prior to COVID-19 recorded in electronic medical records between 20/01/2020 and 05/12/2020. These individuals were compared to historical controls from 2019 with dementia and use of antipsychotics in the 30-days before a visit to a participating healthcare organisation. Propensity score matching for age, sex, race, co-morbidities and use of antidepressants and anticonvulsants was used to balance cohorts with and without COVID-19.
Results: Within the TriNetX network, 8414 individuals with COVID-19, dementia and use of antipsychotics and 31,963 historical controls were identified. After propensity score matching there were 8396 individuals with COVID-19 and 8396 historical controls. The cohorts were well balanced for age, sex, race, co-morbidities and use of antidepressants and anticonvulsants. The odds of 30-day thromboembolic events and all-cause mortality were significantly higher in adults with COVID-19 (Odds Ratios: 1.36 (95% confidence interval (CI): 1.21-1.52) and 1.93 (1.71-2.17), respectively). The number of people with dementia with a visit to a participating healthcare organisation was lower between 20/01/2020 and 05/12/2020 (n = 165,447) compared to the same period in 2019 (n = 217,391), but the proportion receiving antipsychotics increased from 14.7% (95%CI: 14.6-14.9%) to 16.4% (95%CI: 16.2-16.5%), P < .0001.
Conclusions: These findings add to the evidence base that during the COVID-19 pandemic there was an increase in the proportion of people with dementia receiving antipsychotics. The negative effects of antipsychotics in patients with dementia may be compounded by concomitant COVID-19.
MeSH term(s) Aged ; Aged, 80 and over ; Antipsychotic Agents/adverse effects ; COVID-19/diagnosis ; COVID-19/epidemiology ; COVID-19/mortality ; Dementia/diagnosis ; Dementia/drug therapy ; Dementia/mortality ; Dementia/psychology ; Electronic Health Records ; Female ; Humans ; Male ; Prognosis ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Thromboembolism/diagnosis ; Thromboembolism/epidemiology ; Thromboembolism/mortality ; Time Factors
Chemical Substances Antipsychotic Agents
Language English
Publishing date 2021-03-04
Publishing country Netherlands
Document type Journal Article
ZDB-ID 1003347-6
ISSN 1096-1186 ; 0031-6989 ; 1043-6618
ISSN (online) 1096-1186
ISSN 0031-6989 ; 1043-6618
DOI 10.1016/j.phrs.2021.105534
Shelf mark
Zs.A 721: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top